MICHELLE GREIMAN: Open Payments
NPI 1982354817 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 8 companies in 2025. Trend: 2023 $674 · 2024 $187 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $59 |
| ABBVIE INC. | 3 | $56 |
| Janssen Biotech, Inc. | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TALTZ, TREMFYA, Zoryve, RINVOQ, Sotyktu, NEMLUVIO, SKYRIZI, COSENTYX.
Industry payments across IA — which companies pay providers there.
